Back
Akero Therapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
40
AKRO
Akero Therapeutics
Last Price:
21.98
Seasonality Move:
56.48%
Buy
61
MDGL
Madrigal Pharmaceuticals
Last Price:
271.63
Seasonality Move:
1.42%
Sell
40
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $21.93. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $271.67. The Score for MDGL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $21.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $271.67
The current trend is moderately bullish and MDGL is experiencing slight buying pressure.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 47.63 | Sell |
| Chaikin Money Flow: | -89866 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.26 - 24) | Sell |
| Bollinger Bands (100): | (19.84 - 25.98) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.92 | Buy |
| Relative Strength Index (14 RSI): | 55.01 | Buy |
| Chaikin Money Flow: | 13824 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (243.95 - 284.87) | Buy |
| Bollinger Bands (100): | (217.2 - 266.06) | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.08 | Sell |
| 20-day SMA: | 22.96 | Sell |
| 50-day SMA: | 21.16 | Buy |
| 200-day SMA: | 23.03 | Sell |
| 8-day EMA: | 22.77 | Sell |
| 20-day EMA: | 22.51 | Sell |
| 50-day EMA: | 22.06 | Sell |
| 200-day EMA: | 25.22 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 278.48 | Sell |
| 20-day SMA: | 271.8 | Sell |
| 50-day SMA: | 240.5 | Buy |
| 200-day SMA: | 213.86 | Buy |
| 8-day EMA: | 275.88 | Sell |
| 20-day EMA: | 268.91 | Buy |
| 50-day EMA: | 252.98 | Buy |
| 200-day EMA: | 227.65 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.95 per share, and a decrease next year of $0.54 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.29 per share, an increase next quarter of $1.43 per share, a decrease this year of $8.67 per share, and an increase next year of $10.24 per share.
Akero Therapeutics Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||